Edges in Network
| Network | GSE16391_egf1520 - GSE16391 - SiGN-BN HC+Bootstrap |
| Network Description | GGI: a potential predictor of relapse for endocrine-treated breast cancer patients in the BIG 1-98 trial |
| Node | BCL2L1 |
| Upstream (Parents) |
|---|
| (<<) CRLF3 → BCL2L1 |
| (<<) E2F5 → BCL2L1 |
| (<<) ERBB2 → BCL2L1 |
| (<<) GRK6 → BCL2L1 |
| (<<) HPS6 → BCL2L1 |
| (<<) HSP90AB1 → BCL2L1 |
| (<<) MAT2A → BCL2L1 |
| (<<) MCL1 → BCL2L1 |
| (<<) OGFR → BCL2L1 |
| (<<) PIP4K2A → BCL2L1 |
| (<<) RAC2 → BCL2L1 |
| (<<) RXRB → BCL2L1 |
| (<<) SOCS1 → BCL2L1 |
| (<<) YWHAZ → BCL2L1 |
| Downstream (Children) |
|---|
| BCL2L1 → ADORA2B (>>) |
| BCL2L1 → ANKRD37 (>>) |
| BCL2L1 → CDH3 (>>) |
| BCL2L1 → DNAJA1 (>>) |
| BCL2L1 → FLJ35934 (>>) |
| BCL2L1 → GSTZ1 (>>) |
| BCL2L1 → ITPR1 (>>) |
| BCL2L1 → LDLR (>>) |
| BCL2L1 → NFKB2 (>>) |
| BCL2L1 → PRKAB1 (>>) |
| BCL2L1 → RAB5C (>>) |
| BCL2L1 → TGM2 (>>) |
| BCL2L1 → TINF2 (>>) |
| BCL2L1 → TPP1 (>>) |
